• SGC-CBP30: CREBBP/EP300 Bromodomain Inhibitor

  2026-08-19

  SGC-CBP30 is a selective CREBBP/EP300 bromodomain inhibitor for transcriptional coactivator inhibition and epigenetics research. Its reported biochemical potency and cellular activity support mechanistic studies, while lung adenocarcinoma applications remain a research hypothesis rather than a demonstrated therapeutic use.

• TMAO Activates PERK in NAFLD: Study Analysis

  2026-08-19

  A 2024 Toxicology Letters study shows that dietary trimethylamine N-oxide (TMAO) can directly produce steatosis, inflammation, liver injury, and fibrosis in zebrafish, rather than merely correlating with metabolic disease. Its combination of whole-animal modeling with HepG2 and hepatic stellate cell experiments identifies PERK activation as a mechanistic link between TMAO exposure and progressive non-alcoholic fatty liver disease.

• GSK621 as an AMPK Probe in Immunometabolism

  2026-08-18

  GSK621 is an AMPK agonist for dissecting energy sensing, autophagy, lipid metabolism, and AML phenotypes. This article presents an assay-first framework that distinguishes pharmacological AMPK activation from the lysosomal 25-hydroxycholesterol pathway identified in tumor-associated macrophages.

• SCH772984 HCl ERK1/2 Inhibitor Workflows

  2026-08-18

  Build sharper MAPK experiments with SCH772984 HCl by separating rapid ERK signaling changes from delayed proliferation and resistance phenotypes. The workflow also shows how ERK perturbation can be paired with isoform-resolved transcriptional assays in the GT1-7 hypothalamic model.

• PORCN Inhibition in Sclerosteosis: Study Insights

  2026-08-17

  A 2025 Bone Research study evaluates LGK-974 as a pharmacological strategy for limiting excessive Wnt activity in SOST-deficient sclerosteosis. Cell and mouse experiments show reduced osteoblast activity and pathological bone accumulation, while also revealing sex- and tissue-specific differences in target engagement.

• Pexidartinib for TAM Assay Design

  2026-08-17

  Pexidartinib (PLX3397) gives cancer research teams a controllable way to interrogate CSF1R-dependent macrophage abundance and signaling. This practical guide connects compound handling with reporter assays, co-culture models, orthogonal validation, and troubleshooting for tumor microenvironment macrophage modulation.

• Indometacin Sodium: Applied Research Workflows

  2026-08-16

  Indometacin Sodium Trihydrate combines practical COX-1 and COX-2 inhibition with reported effects on Wnt/β-catenin signaling, oligodendrocyte differentiation, and fibrotic-cell behavior. This guide translates those properties into reproducible inflammation, pain, pancreatic stellate cell, and myelin-repair workflows with troubleshooting and assay-design recommendations.

• TaqI Restriction Endonuclease Protocol Guide

  2026-08-15

  TaqI Restriction Endonuclease (SKU K3053) provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA containing the TCGA recognition site. It is intended for research workflows such as cloning and molecular analysis, not for diagnostic or medical use.

• Rosiglitazone as a Probe of Adipose Browning

  2026-08-14

  Rosiglitazone and Brl-49653 provide a powerful PPARγ perturbation for dissecting adipogenesis, beige-fat thermogenesis, and insulin sensitivity modulation. This article explains how to use the compound as a mechanistic benchmark alongside the SETD7–Adcy7–Sirt1–CREB1 axis rather than treating browning markers as standalone proof.

• EZ Cap™ Human PTEN mRNA: Assay Design

  2026-08-14

  Learn how EZ Cap™ Human PTEN mRNA can function as a mechanistic tool for cancer research, from PI3K/Akt pathway assays to lipid nanoparticle delivery studies. This article emphasizes experimental decision-making, delivery biology, and interpretation beyond routine transfection workflows.

• Chloroquine Workflows for Autophagy Research

  2026-08-13

  Chloroquine provides a practical pharmacological lever for testing how lysosomal autophagy influences cementoblast mineralization under mechanical compression. This workflow connects flux-aware assays with the periostin/β-catenin findings of a periodontal regeneration study while clearly separating exploratory research use from clinical translation.

• RPS6 Signaling as a Translational Readout in PDAC

  2026-08-13

  A mechanistic and strategic guide to using RPS6 detection to connect membrane signaling, ribosome biogenesis, and tumor growth in pancreatic ductal adenocarcinoma research.

• GW4064 for Reliable FXR Cell Assays

  2026-08-12

  Learn how GW4064 (SKU B1527) can improve the design and interpretation of FXR-focused viability, proliferation, and cytotoxicity assays. This scenario-driven guide covers potency, solvent handling, photostability, pathway-specific controls, and practical supplier selection.

• ERK1/2 Precision with SCH772984 HCl

  2026-08-11

  SCH772984 HCl offers translational researchers a precise way to interrogate ERK1/2 signaling, resistance in BRAF- and RAS-driven tumors, and the emerging connection between MAPK activity, c-Myc, chromatin state, and TERT transcription in human pluripotent stem cells.

• Tunable Human Intestinal Organoids: Study Insights

  2026-08-11

  Yang and colleagues developed a human small intestinal organoid system that maintains strong proliferation while expanding epithelial cell diversity under a unified culture condition. The study shows that stemness-enhancing pathway modulation can create a tunable platform in which secretory, absorptive, and other intestinal lineages are shifted reversibly or directionally.

15769 records 1/1052 page Next 12345 下5页 Last page